美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sanofi

0.8711

0.0000

成交量：- -

成交額：- -

市值：10.92億

市盈率：0.35

高：0.8711

開：0.8711

低：0.8711

收：0.8711

52周最高：0.8820

52周最低：0.3400

股本：12.54億

流通股本：11.15億

量比：- -

換手率：- -

股息：3.75

股息率：430.96%

每股收益(TTM):2.52

每股收益(LYR):2.52

淨資產收益率：4.97%

總資產收益率：4.03%

市淨率：0.02

市盈率(LYR):0.35

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

美國OTC市場Sanofi盤中異動早盤股價大跌3.19%

ADEL與賽諾菲簽署了一項價值10.4億美元的全球許可協議，涉及新型阿爾茨海默病研究性療法ADEL-Y01ADEL Signs $1.04 Billion Global License Agreement with Sanofi for ADEL-Y01, a Novel investigational Alzheimer's Disease Therapy

美國OTC市場Sanofi漲2.32% 股價突破100美元大關

美國OTC市場Sanofi盤中異動快速上漲3.70%報106.31美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/GCVRZ"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GCVRZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GCVRZ\",,,,,undefined,":{"symbol":"GCVRZ","market":"US","secType":"STK","nameCN":"Sanofi","latestPrice":0.8711,"timestamp":1583269200000,"preClose":0.8711,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":1114622547,"shares":1254041488,"eps":2.519335,"marketStatus":"停牌","change":0,"latestTime":"02-10 04:43:04 EST","open":0.8711,"high":0.8711,"low":0.8711,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.519335,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.8711,"dividendRate":4.027632,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GCVRZ\",,,,,undefined,":{"symbol":"GCVRZ","floatShares":1114622547,"roa":"4.03%","roe":"4.97%","lyrEps":2.519335,"shares":1254041488,"dividePrice":3.75406,"high":0.8711,"amplitude":0,"preClose":0.8711,"low":0.8711,"week52Low":0.34,"pbRate":"0.02","week52High":0.882,"institutionHeld":0.1803,"latestPrice":0.8711,"eps":2.519335,"divideRate":4.309563,"volume":0,"delay":0,"ttmEps":2.519335,"open":0.8711,"prevYearClose":0.8602},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GCVRZ\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GCVRZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GCVRZ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GCVRZ\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2600096814","title":"美國OTC市場Sanofi盤中異動 早盤股價大跌3.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600096814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600096814?lang=zh_tw&edition=fundamental","pubTime":"2026-01-02 22:46","pubTimestamp":1767365195,"startTime":"0","endTime":"0","summary":"北京时间2026年01月02日22时46分，美国OTC市场Sanofi股票出现波动，股价急速跳水3.19%。截至发稿，该股报94.19美元/股，成交量300股，换手率0.00%，振幅0.00%。美国OTC市场Sanofi股票所在的制药行业中，整体跌幅为0.90%。美国OTC市场Sanofi公司简介：赛诺菲专注于免疫学、疫苗和罕见病领域的药物开发和销售。总收入的约 45% 来自美国，20% 来自欧洲，6% 来自中国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102224635a6ebf0c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102224635a6ebf0c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNYNF","BK4007","GCVRZ"],"gpt_icon":0},{"id":"2592514799","title":"ADEL與賽諾菲簽署了一項價值10.4億美元的全球許可協議，涉及新型阿爾茨海默病研究性療法ADEL-Y01ADEL Signs $1.04 Billion Global License Agreement with Sanofi for ADEL-Y01, a Novel investigational Alzheimer's Disease Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2592514799","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592514799?lang=zh_tw&edition=fundamental","pubTime":"2025-12-16 14:41","pubTimestamp":1765867260,"startTime":"0","endTime":"0","summary":"The total potential value of the agreement is up to $1.04 billion. ADEL will receive a non-refundable upfront payment of $80 million and is eligible to receive additional payments contingent upon the achievement of specified development and commercial milestones. Additionally, ADEL is entitled to receive tiered royalties on net sales ranging up to double-digit percentages..协议的总潜在价值高达 10.4 亿美元。ADEL spearheaded the entire discovery and preclinical development of ADEL-Y01 using its proprietary neural disease research and development platform. Since 2020, ADEL has been co-developing the asset through a joint research and development agreement with Oscotec Inc. Currently, ADEL-Y01 is undergoing a global Phase 1 clinical trial  under an Investigational New Drug  application approved by the U.S.ADEL利用其专有的神经疾病研发平台，引领了ADEL-Y01的整个发现和临床前开发过程。自2020年起，ADEL通过与Oscotec Inc.签订的联合研发协议共同开发该资产。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216144226a6a844ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216144226a6a844ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNYNF","BK4007","GCVRZ"],"gpt_icon":0},{"id":"2586040284","title":"美國OTC市場Sanofi漲2.32% 股價突破100美元大關","url":"https://stock-news.laohu8.com/highlight/detail?id=2586040284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586040284?lang=zh_tw&edition=fundamental","pubTime":"2025-11-26 04:32","pubTimestamp":1764102742,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日04时32分，美国OTC市场Sanofi股票出现异动，股价急速拉升2.32%。截至发稿，该股报100.00美元/股，成交量3.8644万股，换手率0.00%，振幅0.00%。美国OTC市场Sanofi股票所在的制药行业中，整体涨幅为2.81%。美国OTC市场Sanofi公司简介：赛诺菲专注于免疫学、疫苗和罕见病领域的药物开发和销售。总收入的约 45% 来自美国，20% 来自欧洲，6% 来自中国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126043223951a28d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126043223951a28d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNYNF","GCVRZ","BK4007"],"gpt_icon":0},{"id":"2584675709","title":"美國OTC市場Sanofi盤中異動 快速上漲3.70%報106.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584675709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584675709?lang=zh_tw&edition=fundamental","pubTime":"2025-11-17 23:01","pubTimestamp":1763391663,"startTime":"0","endTime":"0","summary":"北京时间2025年11月17日23时01分，美国OTC市场Sanofi股票出现波动，股价大幅拉升3.70%。截至发稿，该股报106.31美元/股，成交量131股，换手率0.00%，振幅0.00%。美国OTC市场Sanofi股票所在的制药行业中，整体涨幅为0.41%。美国OTC市场Sanofi公司简介：赛诺菲专注于疫苗、免疫学、肿瘤学、心血管疾病、糖尿病和非处方治疗药物的开发和销售。超过40%的总收入来自美国，25%来自欧洲。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117230103a6ffad8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117230103a6ffad8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SNYNF","GCVRZ"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GCVRZ\",params:#limit:6,delay:false,,,undefined,":[]}}